rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Aaron Bloomer

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, ResMed; EVP, Chief Financial Officer, Exact Sciences.

In numbers

Trades disclosed
26
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
0
First trade
24 Feb 2025
Last trade
14 Aug 2026
Last filed
1 Oct 2026

Companies traded

Where they are an officer
RMD ResMedOfficer · Medical Devices · last 14 Aug 20260 buys · 0 sells
Exact SciencesOfficer · Diagnostics & Labs · last 23 Mar 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
14 Aug 2026filed 1 Oct 2026RMD ResMedMedical DevicesSEC FORM 4 Code A—9,072 at $0.00filing
23 Mar 2026filed 23 Mar 2026Exact SciencesDiagnostics & LabsSEC FORM 4 Code A—89,911 at $0.00filing
23 Mar 2026filed 23 Mar 2026Exact SciencesDiagnostics & LabsSEC FORM 4 Code D—138,679filing
23 Mar 2026filed 23 Mar 2026Exact SciencesDiagnostics & LabsSEC FORM 4 Code D—417filing
23 Mar 2026filed 23 Mar 2026Exact Sciencesoption or derivativeSEC FORM 4 Code D—4,395filing
23 Mar 2026filed 23 Mar 2026Exact Sciencesoption or derivativeSEC FORM 4 Code D—28,063filing
23 Mar 2026filed 23 Mar 2026Exact Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code D—4,395filing
23 Mar 2026filed 23 Mar 2026Exact Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code D—28,063filing
23 Mar 2026filed 23 Mar 2026Exact SciencesSEC FORM 4 Code A—89,911 at $0.00filing
23 Mar 2026filed 23 Mar 2026Exact SciencesSEC FORM 4 Code D—138,679filing
23 Mar 2026filed 23 Mar 2026Exact SciencesSEC FORM 4 Code D—417filing
25 Feb 2026filed 27 Feb 2026Exact Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—28,063 at $0.00filing
25 Feb 2026filed 27 Feb 2026Exact Sciencesoption or derivativeSEC FORM 4 Code A—28,063 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact Sciencesoption or derivativeSEC FORM 4 Code M—38,715 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact Sciencesoption or derivativeSEC FORM 4 Code M—24,384 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact SciencesSEC FORM 4 Code M—38,715 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact SciencesSEC FORM 4 Code F$1.7M17,151 at $101.82filing
23 Dec 2025filed 30 Dec 2025Exact SciencesSEC FORM 4 Code M—24,384 at $0.00filing
23 Dec 2025filed 30 Dec 2025Exact SciencesSEC FORM 4 Code F$1.1M10,803 at $101.82filing
15 Apr 2025filed 17 Apr 2025Exact Sciencesoption or derivativeSEC FORM 4 Code M—11,566 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Michael J. FarrellChairman and CEO · Chairman and CEO at Resmed, filing Form 4 there in the last year
Michael J. RiderGlobal General Counsel · Global General Counsel at Resmed, filing Form 4 there in the last year
Justin LeongChief Product Officer · Chief Product Officer at Resmed, filing Form 4 there in the last year
Peter C. FarrellDirector · Director at Resmed, filing Form 4 there in the last year
Brett SandercockChief Financial Officer · Chief Financial Officer at Resmed, filing Form 4 there in the last year